Paper - WANFANG MED ONLINE

You Position: Home > Paper

Progress of PET/CT in the radiotherapy of esophageal carcinoma

( views:310, downloads:172 )

Author:: No author available

Journal Title:: Chinese Journal of Nuclear Medicine and Molecular Imaging

Issue:: 5

DOI:: 10.3760/cma.j.issn.2095-2848.2012.05.021

Key Word:: 食管肿瘤;放射疗法;体层摄影术,发射型计算机;体层摄影术,X线计算机;发展趋势;Esophageal neoplasms;Radiotherapy;Tomography,emission-computed;Tomography,X-ray computed;Trends

Abstract： Esophageal carcinoma is one of the most severe cancers; while,radiotherapy is one of the most important treatment modalities.However,traditional imaging such as CT and endoscopic ultrasound (EUS) can only provide anatomical information during radiotherapy simulation,orientation and evaluation of the therapeutic effect of chemoradiotherapy.But in recent years,18F-FDG PET/CT with integration of functional and anatomical information has been used more and more widely in tumor diagnosis,staging,and evaluating therapeutic effect and prognosis.This paper summarizes recent progress in the application of 18F-FDG PET/CT for diagnosis,staging,and radiotherapy of esophageal cancer.

Reference

[1]邢军,李建彬,刘娟,等.PET-CT图像融合在食管癌精确放疗中的应用[J].2007,(3).
[2]郭洪波,于金明,张百江,等.18F-FDG PET/CT显像对食管癌原发灶长度的测量[J].2007,(3).
[3]陈虞梅,陈涛,童林军,等.应用18FDG PET评价食管癌新辅助治疗疗效的价值[J].2010,(9).
[4]谭茹,朱仁娟,葛全序,等.18F-FDG PET/CT和增强MSCT评价食管癌淋巴结转移[J].2007,(6).
[5]袁双虎,于金明,于甬华,等.18F-脱氧葡萄糖PET-CT检测食管癌病变长度的临床价值[J].2006,(5).
[6]苏新辉,吴华,黄劲雄,等.99Tcm-HL91乏氧显像在恶性肿瘤治疗后随访中的应用[J].2009,(3).
[7]Bryant AS,Ohja B,Bartolucci AA,etc.The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy.[J].2005,129(6).
[8]Han D,Fu Z,Zhong X,etc.Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus.[J].2010,76(4).
[9]Kamangar F,Dores GM,Anderson WF.Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.[J].2006,24(14).
[10]Balfe DM,Meyers BF,Putnam-JB Jr,etc.The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial.[J].2007,133(3).
[11]Metges JP,Hatt M,Pradier O,etc.Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer.[J].2011,52(3).
[12]Makino T,Hatazawa J,Miyata H,etc.Utility of response evaluation to neo-adjuvant chemotherapy by (18)F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma.[J].2010,148(5).
[13]Blackstock,A.W.,Aklilu,M.,Clark,P.,etc.Outcomes of patients with esophageal cancer staged with [18F]fluorodeoxyglucose positron emission tomography (FDG-PET): Can postchemoradiotherapy FDG-PET predict the utility of resection?[J].2010,28(31).
[14]Hosono M,Okada M,Murakami T,etc.Integrated FDG-PET/CT compared with intravenous contrast-enhanced CT for evaluation of metastatic regional lymph nodes in patients with resectable early stage esophageal cancer.[J].2009,23(1).
[15]Holalkere, Nagaraj S.,Colen, Rivka R.,Choi, Noah C.,etc.Adenocarcinomas of the esophagus: Response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopathologic and clinical response evaluation[J].2008,89(3).
[16]Muijs CT,Schreurs LM,Busz D.Consequences of additional use of PET information for target volume delineation and radiotherapy dose distribution for esophageal cancer.[J].2009,93(3).
[17]Colen RR,Sahani DV,Roedl JB,etc.Metabolic tumor width parameters as determined on PET/CT predict disease-free survival and treatment response in squamous cell carcinoma of the esophagus.[J].2009,11(1).
[18]Salahudeen HM,Scarsbrook AF,Naik K,etc.Impact of the introduction of integrated PET-CT into the preoperative staging pathway of patients with potentially operable oesophageal carcinoma.[J].2008,63(7).
[19]Clain JE,Jensen E,Murray JA,etc.Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer.[J].2005,7(6).
[20]Kato H,Kimura H,Nakajima M,etc.The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer.[J].2008,20(4).
[21]Choi JY,Hyun SH,Shim Y.Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma.[J].2010,17(1).
[22]Li D,Kong FM,Fu Z,etc.Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus.[J].2009,73(1).
[23]Wahl RL,Jacene H,Kasamon Y,etc.From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.[J].2009,50(Suppl.1).